Michele Carbone: Gene hunter of Hawai’i
Michele Carbone, MD, PhD, investigated an epidemic of mesothelioma in remote villages in Turkey and discovered a new cancer syndrome caused by an inherited anomaly. An AACR grant supported his research.
Research Funding Impact
Since 1993, the AACR has awarded more than $540 million in grants to fund meritorious research projects across the spectrum of cancer science, including basic, translational, and clinical research. See how the AACR grants program has contributed to the AACR's mission.
Search/Filter
Loading...
A Neurosurgeon Speaks on the Impact of an AACR-Conquer Cancer Foundation of ASCO Young Investigator Award
The AACR-Conquer Cancer Foundation (CCF) of ASCO Young Investigator Award for Translational Cancer Research funds a physician-scientist during the transition from a fellowship program to a faculty appointment. 2020 Recipient Dr. Mathios speaks on the grant's impact on his research and career.
Because Cancer is Not an Island: 2020 AACR-The Mark Foundation for Cancer Research “Science of the Patient” SOP Grants
The 2020 AACR-The Mark Foundation for Cancer Research “Science of the Patient” SOP Grants Program seeks to stimulate novel research on the interplay between patient physiology and the tumor. The five grantees have been conducting breakthrough research -- studying cancer not as an isolated phenomenon but as a systemic disease.
From Stars to Cancer: The Journey of Sarah Bohndiek
Sarah Bohndiek, PhD, of the University of Cambridge. once thought she wanted to be an astrophysicist. She trained instead in radiation physics, and a grant from the AACR and Amgen helped her move into molecular imaging and early detection of cancer.
Making an Impact on Rare Tumors
A grant from the AACR in 2000 helped Karlyne Reilly, PhD, launch her career in cancer research. She is now head of the Rare Tumor Initiative at the National Cancer Institute and works to involve scientists, patients, family members, advocates, and healthcare providers in the search for treatments for rare cancers.
PanCAN-AACR Grantee Shows Potential Dual Anti-cancer and Anti-cachexia Benefits of Targeting Perp in Pancreatic Cancer
Cachexia is a muscle-wasting syndrome that is commonly found in pancreatic and other cancer patients. A group led by 2017 Pancreatic Cancer Action Network-AACR Career Development Award recipient Jason D. Doles, PhD, identified Perp as a novel tumor promoter and mediator of cancer-associated muscle wasting.
AACR-AstraZeneca Clinical Immuno-oncology Research Training Fellowship: A Formative Experience
The AACR-AstraZeneca Clinical Immuno-oncology Research Training Fellowship Program is designed to encourage exceptional clinical research by bridging close collaboration between academia and industry. 2020 grant recipient Justin A. Chen, shares his perspectives on the impact of the grant.
Getting Ahead of Treatment Resistance in Multiple Myeloma
2019 AACR-Amgen Fellow, Julia Frede, PhD, reported in Nature Cell Biology, how treatment can induce the expression of a distinct set of actionable immunotherapy targets in multiple myeloma, such as CXCR4, which can be exploited to keep treatment resistance at bay.
Propelling Progress in Pancreatic Cancer Research
For David A. Tuveson, MD, PhD, FAACR, a career development grant from the AACR initiated the development of a model to help understand one of the deadliest and most difficult-to-treat types of cancer.
Sunil Hingorani and the Small Patients
At the start of his career, Sunil Hingorani, MD, PhD, now at the Fred Hutchinson Cancer Research Center, had a life-altering experience in caring for a patient with pancreatic cancer. A grant from the AACR in 2005 led him into an investigation that changed his approach to the disease.